The Role of Platelet-Rich Plasma in the Management of Sensorineural Hearing Loss: Current Evidence and Emerging Trends
Open Access
- 4 September 2024
- journal article
- research article
- Published by Springer Nature in Cureus
- Vol. 16 (9) , e68646
Abstract
Sensorineural hearing loss (SNHL) is a common form of hearing impairment characterized by damage to the inner ear or auditory nerve, resulting in significant communication difficulties and reduced quality of life. Current treatment options, including hearing aids, cochlear implants, and corticosteroids, primarily focus on symptom management and do not address the underlying pathophysiological damage. Platelet-rich plasma (PRP), an autologous concentrate rich in platelets and growth factors, has emerged as a potential regenerative therapy due to its ability to promote tissue repair and cellular regeneration. This review provides a comprehensive overview of the role of PRP in the management of SNHL, examining the current evidence from preclinical and clinical studies. We discuss the mechanisms through which PRP may promote auditory tissue regeneration and repair, analyze its efficacy and safety profile, and explore innovative approaches and future directions in its application for SNHL. Despite promising preliminary findings, further research is needed to optimize PRP protocols, establish standardized treatment guidelines, and conduct large-scale randomized controlled trials to validate efficacy. This review aims to highlight the potential of PRP as a novel therapeutic strategy in treating SNHL and its possible integration into current clinical practices, offering new hope for patients with this debilitating condition.Keywords
This publication has 48 references indexed in Scilit:
- Intratympanic Gels for Inner Ear Disorders: A Scoping Review of Clinical TrialsOtolaryngology–Head and Neck Surgery, 2024
- Substantial Variability in Platelet‐Rich Plasma Composition Is Based on Patient Age and Baseline Platelet CountArthroscopy, Sports Medicine, and Rehabilitation, 2023
- History of autologous platelet‐rich plasma: A short reviewJournal of Cosmetic Dermatology, 2021
- Sensorineural hearing loss (SNHL) as an adverse event following immunization (AEFI): Case definition & guidelines for data collection, analysis, and presentation of immunization safety dataVaccine, 2020
- Role of Platelet Rich Plasma in TympanoplastyIndian Journal of Otolaryngology and Head & Neck Surgery, 2020
- New molecular therapies for the treatment of hearing lossPharmacology & Therapeutics, 2019
- Factors associated with clinical trials that fail and opportunities for improving the likelihood of success: A reviewContemporary Clinical Trials Communications, 2018
- The limitations of using randomised controlled trials as a basis for developing treatment guidelinesEvidence Based Mental Health, 2017
- Cellular mechanisms of noise-induced hearing lossHearing Research, 2017
- Steroids for idiopathic sudden sensorineural hearing lossCochrane Database of Systematic Reviews, 2013